• Exchange: London
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

e-Therapeutics PLC

+ Add to Watchlist

ETX:LN

28.500 GBp 1.500 5.56%

As of 11:30:00 ET on 11/27/2014.

Snapshot for e-Therapeutics PLC (ETX)

Open: 27.500 Day's Range: 27.500 - 28.500 Volume: 91,961
Previous Close: 27.000 52wk Range: 20.000 - 35.500 1-Yr Rtn: +2.70%

Stock Chart for ETX

No chart data available.
  • ETX:LN 28.500
  • 1D
  • 1M
  • 1Y
27.000
Interactive ETX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ETX

Current P/E Ratio (ttm) -
Estimated P/E(01/2015) -
Relative P/E vs. UKX -
Earnings Per Share (GBP) (ttm) -0.0260
Est. EPS (GBP) (01/2015) -0.0350
Est. PEG Ratio -
Market Cap (M GBP) 75.33
Shares Outstanding (M) 264.32
30 Day Average Volume 28,094
Price/Book (mrq) 1.8562
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ETX

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for ETX

e-Therapeutics PLC is a systems biology drug discovery company. The Company uses computers to predict the effects of intervention to proteins in a cell.

Malcolm P YoungChief Executive/FounderSteve MedlicottFinance Director
Stephen Self "Steve"Director:DevelopmentSean T NicolsonSecretary
More Company Profile & Key Executives for ETX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil